Intensity Therapeutics, Inc. (INTS) has a market capitalization of $10M and trades at $5.30. The 52-week range is 4.625-50.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.6, Earnings Per Share (EPS) of $-8.56.
The stock has a beta of 4.23, operates in the Healthcare sector.
